|Articles|September 25, 1998

The American Journal of Managed Care

  • September 1998 - Special Issue
  • Volume 4
  • Issue 2 SP

Use of an Intravenous Contrast Agent (Optison) to Enhance Echocardiography: Efficacy and Cost Implications

Download PDF: Use of an Intravenous Contrast Agent (Optison) to Enhance Echocardiography: Efficacy and Cost Implications

Articles in this issue

over 27 years ago

Technology Assessment of Medical Devices

over 27 years ago

Technology Assessment, Coverage Decisions, and Conflict: The Role of Guidelines

over 27 years ago

Technology Assessment of Medical Devices at the Center for Devices and Radiological Health

over 27 years ago

Role of Technology Assessment in Health Benefits Coverage for Medical Devices

over 27 years ago

Transmyocardial Laser Revascularization: A Qualitative Systematic Review

over 27 years ago

Device Evaluation and Coverage Policy in Workers' Compensation: Examples from Washington State

over 27 years ago

The Limited State of Technology Assessment for Medical Devices: Facing the Issues

over 27 years ago

Healthcare Technology Assessment: Methods, Framework, and Role in Policy Making

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs
Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

View more
Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care
AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

View more
Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo
Alt TextAlt Text